School of Engineering
Showing 1-41 of 41 Results
-
Paul Schmiedmayer
Postdoctoral Scholar, Bioengineering
Current Research and Scholarly InterestsPaul Schmiedmayer's research applies computer science research to digital health innovations incorporating. These include machine learning applications and deployments, heterogeneous connected devices, health standards such as FHIR, and software engineering best practices.
He is developing the Stanford Spezi framework and ecosystem, enabling the rapid development of digital health innovations, and is a co-instructor of the Building for Digital Health (CS342) course at Stanford University. -
Mohit Singhala
Postdoctoral Scholar, Bioengineering
BioMohit is an Innovation Fellow at the Stanford Byers Center for Biodesign. He completed his PhD at Johns Hopkins, where he studied haptics and medical robotics. He built custom electromechanical testbeds to quantitatively assess how humans perceive touch. He concurrently served as an innovator-in-residence at Johns Hopkins CBID, where he previously earned his MSE in bioengineering innovation and design. He comes from India, where he completed his undergraduate training in mechanical engineering.
He has invented several patented and patent-pending medical devices, performed primary ethnography in multiple countries, and received funding from organizations such as the Gates Foundation. He continues his global health collaborations in India, Uganda and Zambia. Mohit also played a crucial role in Hopkins’ COVID-19 pandemic response, most notably helping devise an emergency dialysate production method that was adopted by multiple healthcare facilities. -
Patrick Slade
Postdoctoral Scholar, Bioengineering
Biohttps://www.pat-slade.com/
-
Hyongsok Tom Soh
Professor of Radiology (Early Detection), of Electrical Engineering, of Bioengineering and, by courtesy, of Chemical Engineering
BioDr. Soh received his B.S. with a double major in Mechanical Engineering and Materials Science with Distinction from Cornell University and his Ph.D. in Electrical Engineering from Stanford University. From 1999 to 2003, Dr. Soh served as the technical manager of MEMS Device Research Group at Bell Laboratories and Agere Systems. He was a faculty member at UCSB before joining Stanford in 2015. His current research interests are in analytical biotechnology, especially in high-throughput screening, directed evolution, and integrated biosensors.
-
Sandya Subramanian
Postdoctoral Scholar, Bioengineering
Current Research and Scholarly InterestsI would like to focus on platform technology development for at-home monitoring of chronic disease, by studying gut-autonomic nervous system interactions. I am trained as an engineer and computational researcher, and I have experience developing computational algorithms from physiology, collecting data from patients in complex clinical scenarios, and collaborating with diverse clinical and regulatory teams. I am developing expertise in hardware-software interfacing and bioelectronics.
-
James Swartz
James H. Clark Professor in the School of Engineering and Professor of Chemical Engineering and of Bioengineering
On Leave from 10/01/2022 To 06/30/2023Current Research and Scholarly InterestsProgram Overview
The world we enjoy, including the oxygen we breathe, has been beneficially created by biological systems. Consequently, we believe that innovative biotechnologies can also serve to help correct a natural world that non-natural technologies have pushed out of balance. We must work together to provide a sustainable world system capable of equitably improving the lives of over 10 billion people.
Toward that objective, our program focuses on human health as well as planet health. To address particularly difficult challenges, we seek to synergistically combine: 1) the design and evolution of complex protein-based nanoparticles and enzymatic systems with 2) innovative, uniquely capable cell-free production technologies.
To advance human health we focus on: a) achieving the 120 year-old dream of producing “magic bullets”; smart nanoparticles that deliver therapeutics or genetic therapies only to specific cells in our bodies; b) precisely designing and efficiently producing vaccines that mimic viruses to stimulate safe and protective immune responses; and c) providing a rapid point-of-care liquid biopsy that will count and harvest circulating tumor cells.
To address planet health we are pursuing biotechnologies to: a) inexpensively use atmospheric CO2 to produce commodity biochemicals as the basis for a new carbon negative chemical industry, and b) mitigate the intermittency challenges of photovoltaic and wind produced electricity by producing hydrogen either from biomass sugars or directly from sunlight.
More than 25 years ago, Professor Swartz began his pioneering work to develop cell-free biotechnologies. The new ability to precisely focus biological systems toward efficiently addressing new, “non-natural” objectives has proven tremendously useful as we seek to address the crucial and very difficult challenges listed above. Another critical feature of the program is the courage (or naivete) to approach important objectives that require the development and integration of several necessary-but- not-sufficient technology advances.
